Showing results (21-30 of 84) with videos related to

Sort By:
Pageof 9
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 2, 2017
Correlation of clinicopathologic features and lung squamous cell carcinoma subtypes according to the 2015 WHO classificationRongrong Chen, Zhengping Ding, Lei Zhu, et al.
Oncotargets and Therapy|March 14, 2014
The predictive role of pretreatment epidermal growth factor receptor T790M mutation on the progression-free survival of tyrosine-kinase inhibitor-treated non-small cell lung cancer patients: a meta-analysisDing Ding, Yongfeng Yu, Ziming Li, et al.
Annals of Translational Medicine|March 14, 2022
Treatment preferences for epidermal growth factor receptor mutation-positive non-small cell lung cancer with brain metastasis: a large-scale survey from Chinese oncologistsYongfeng Yu, Jie Qian, Lan Shen, et al.
Frontiers in Genetics|February 23, 2023
Comprehensive molecular characterizations of stage I-III lung adenocarcinoma with tumor spread through air spacesRonghao Ye, Yongfeng Yu, Ruiying Zhao, et al.
Frontiers in Oncology|October 23, 2023
Immunotherapy strategies for EGFR-mutated advanced NSCLC after EGFR tyrosine-kinase inhibitors failureXingyuan Li, Huayan Huang, Yingjia Sun, et al.
Cancer Medicine|July 27, 2016
Prognostic value of MMP9 activity level in resected stage I B lung adenocarcinomaYongfeng Yu, Zhengping Ding, Hong Jian, et al.
Acta Biochimica Et Biophysica Sinica|August 8, 2014
Everolimus and zoledronic acid--a potential synergistic treatment for lung adenocarcinoma bone metastasisYongfeng Yu, Zhengbo Song, Shunfang Yang, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 4, 2018
Lung squamous cell carcinoma: A postoperative recurrence analysis of keratinizing and nonkeratinizing subtypesRongrong Chen, Xiaohua Yang, Zhengping Ding, et al.
Frontiers in Immunology|November 21, 2022
<i>SMO</i> mutation predicts the effect of immune checkpoint inhibitor: From NSCLC to multiple cancersWenxiang Ji, Xiaomin Niu, Yongfeng Yu, et al.
Lung|June 30, 2015
Maintenance Therapy Improves Survival Outcomes in Patients with Advanced Non-small Cell Lung Cancer: A Meta-analysis of 14 StudiesShun Lu, Yongfeng Yu, Zhiwei Chen, et al.
Pageof 9